Insufficient scRNA-seq data for expression of PGLYRP2 at single-cell level.
Insufficient scRNA-seq data for expression of PGLYRP2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 5883.92 | 226 / 226 | 94% | 115.75 | 381 / 406 |
breast | 74% | 65.80 | 338 / 459 | 57% | 9.85 | 642 / 1118 |
peripheral blood | 89% | 21.26 | 826 / 929 | 0% | 0 | 0 / 0 |
spleen | 85% | 20.49 | 204 / 241 | 0% | 0 | 0 / 0 |
prostate | 75% | 39.17 | 183 / 245 | 1% | 0.02 | 4 / 502 |
bladder | 62% | 6.24 | 13 / 21 | 9% | 0.27 | 44 / 504 |
skin | 63% | 11.42 | 1144 / 1809 | 1% | 0.02 | 6 / 472 |
lung | 50% | 4.19 | 290 / 578 | 3% | 0.05 | 29 / 1155 |
uterus | 48% | 6.24 | 82 / 170 | 2% | 0.15 | 8 / 459 |
thymus | 41% | 3.21 | 267 / 653 | 1% | 0.06 | 9 / 605 |
intestine | 35% | 3.87 | 339 / 966 | 1% | 0.26 | 5 / 527 |
adipose | 30% | 2.90 | 366 / 1204 | 0% | 0 | 0 / 0 |
stomach | 26% | 1.94 | 94 / 359 | 3% | 0.07 | 10 / 286 |
kidney | 21% | 1.51 | 19 / 89 | 6% | 0.27 | 56 / 901 |
esophagus | 14% | 0.93 | 208 / 1445 | 4% | 0.12 | 8 / 183 |
blood vessel | 12% | 0.84 | 164 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 11% | 0.67 | 37 / 328 | 1% | 0.02 | 1 / 178 |
adrenal gland | 8% | 0.52 | 21 / 258 | 0% | 0 | 0 / 230 |
ovary | 7% | 0.32 | 12 / 180 | 1% | 0.04 | 6 / 430 |
heart | 7% | 0.52 | 58 / 861 | 0% | 0 | 0 / 0 |
brain | 6% | 0.40 | 169 / 2642 | 0% | 0 | 0 / 705 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.06 | 2 / 45 |
muscle | 2% | 0.19 | 19 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_0009253 | Biological process | peptidoglycan catabolic process |
GO_0050830 | Biological process | defense response to Gram-positive bacterium |
GO_0001519 | Biological process | peptide amidation |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0051701 | Biological process | biological process involved in interaction with host |
GO_0016045 | Biological process | detection of bacterium |
GO_0045087 | Biological process | innate immune response |
GO_0032827 | Biological process | negative regulation of natural killer cell differentiation involved in immune response |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0008745 | Molecular function | N-acetylmuramoyl-L-alanine amidase activity |
GO_0042834 | Molecular function | peptidoglycan binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0016019 | Molecular function | peptidoglycan immune receptor activity |
Gene name | PGLYRP2 |
Protein name | N-acetylmuramoyl-L-alanine amidase (EC 3.5.1.28) (Peptidoglycan recognition protein 2) (Peptidoglycan recognition protein long) (PGRP-L) Peptidoglycan recognition protein 2 |
Synonyms | PGLYRPL UNQ3103/PRO10102 PGRPL |
Description | FUNCTION: May play a scavenger role by digesting biologically active peptidoglycan (PGN) into biologically inactive fragments. Has no direct bacteriolytic activity. . |
Accessions | ENST00000594637.1 M0QYW3 ENST00000340880.5 [Q96PD5-1] ENST00000292609.8 [Q96PD5-2] Q96PD5 ENST00000601792.1 M0R2W8 |